Expiring patents force a sales staff slim-down, but the drug maker emphasizes it is not eliminating its sales force.
Business briefs: Reps mum on adverse events; FCC’s new mHealth director; med schools tighten speaking limits
April 11, 2013
6:05 pm
A study finds sales reps find time to talk benefits, but not risks, even when touting black-box drugs; FCC has named its new mHealth director; pharma scaled back its food budgets last year; and AMSA says 18 med schools now ban faculty from speakers bureau participation
Success in emerging markets hinges on broad network
At first blush, Accenture’s survey of pharma execs looks like more bad news for sales forces, but the firm tells MM&M that the sales overhauls are about more than reducing headcounts.
Days after announcing a sharp downsizing, the patent expiry-plagued company said it will eliminate an additional 2,300 jobs, raising the tally of cuts to more than 5,000 through 2016.
Deploying digital frameworks across large pharmaceutical organizations is a tricky business the world over, as execs convening in Barcelona can tell you. Securing local buy-in is essential to a successful multichannel roll-out.
Business Briefs: Novo, FDA, Biologics
March 19, 2013
4:15 pm
Novo’s weight-loss news fails to lift investor mood; GAO wants FDA to do more biologics topped 2012 sales.